Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China flag China · Delayed Price · Currency is CNY
14.42
+0.04 (0.28%)
Jul 31, 2026, 3:04 PM CST

SHE:300181 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
718.33680.88804.67931.981,082232.3
Trading Asset Securities
---15110.8365.52
Cash & Short-Term Investments
718.33680.88804.671,0831,093297.82
Cash Growth
-3.06%-15.38%-25.70%-0.91%266.97%-5.39%
Accounts Receivable
1,2561,139783.33532.42510.07337.33
Other Receivables
20.6918.0118.189.0224.4226.77
Receivables
1,2761,157801.52541.44534.5364.1
Inventory
565.72531.81523.75426.52318.83273.59
Prepaid Expenses
-3.970-7.87-
Other Current Assets
37.7817.2447.515.535.456.16
Total Current Assets
2,5982,3912,1772,0561,960941.67
Property, Plant & Equipment
1,4841,4271,2201,060972.41806.32
Long-Term Investments
492.99411.57254.64179.7392.36650.67
Goodwill
321.37130.32130.32130.32130.32130.32
Other Intangible Assets
280.1682.4275.0871.2763.0464.89
Long-Term Deferred Tax Assets
31.9531.7930.425.525.1415.51
Long-Term Deferred Charges
51.2450.0935.5825.4925.4225.6
Other Long-Term Assets
70.95186.7268.9178.0774.76113.55
Total Assets
5,3314,7123,9923,6273,6432,749

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
517.03425.26482.41433.85468.88296.77
Accrued Expenses
25.32127.2586.5382.2478.3262.33
Short-Term Debt
715.32660.09377.31193.06138.16178.2
Current Portion of Long-Term Debt
---10.010.01-
Current Portion of Leases
3.753.193.352.492.834.21
Current Income Taxes Payable
159.4169.2652.5432.6526.5916.46
Current Unearned Revenue
8.765.2614.452.2314.143.06
Other Current Liabilities
245.3148.6439.4638.282623.55
Total Current Liabilities
1,6751,3391,056794.83754.94584.58
Long-Term Debt
29.1611.6630.66-10-
Long-Term Leases
18.317.0718.2716.6922.1324.27
Long-Term Unearned Revenue
26.7827.6526.519.919.7622.37
Long-Term Deferred Tax Liabilities
88.217541.0321.6876.24134.1
Total Liabilities
1,8371,4701,173853.09883.07765.31

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
701.39701.39701.39701.39701.39608.62
Additional Paid-In Capital
1,1511,1421,1351,1351,135340.48
Retained Earnings
1,4571,2571,041849.32676.8525.52
Treasury Stock
-111.88-111.88-203.97---
Comprehensive Income & Other
227.42191.6294.6342.66190.19369.44
Total Common Equity
3,4243,1802,7692,7292,7041,844
Minority Interest
68.9761.2550.5645.256.18139.15
Shareholders' Equity
3,4933,2412,8192,7742,7601,983
Total Liabilities & Equity
5,3314,7123,9923,6273,6432,749

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
766.53692.01429.59222.25173.13206.67
Net Cash (Debt)
-48.2-11.13375.08860.73919.7791.15
Net Cash Growth
---56.42%-6.42%909.09%-
Net Cash Per Share
-0.07-0.020.541.241.520.15
Filing Date Shares Outstanding
693.22693.22692.47701.39701.39608.62
Total Common Shares Outstanding
693.22693.22686.49701.39701.39608.62
Working Capital
923.181,0521,1211,2621,205357.1
Book Value Per Share
4.944.594.033.893.853.03
Tangible Book Value
2,8232,9672,5632,5272,5101,649
Tangible Book Value Per Share
4.074.283.733.603.582.71
Buildings
-1,2231,014962.71832.63678.11
Machinery
-580.69529.12467.55432.59412.82
Construction In Progress
-173.97161.4361.1478.0640.29